Arzneiwerk AG VIDA (FRA:TLIK) 1-Year Sharpe Ratio: 1.01 (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TLIK Arzneiwerk AG VIDA FRA:TLIK
40 GF Score
Price €0.21
! 7 Warning Signs
View Full Analysis

What is Arzneiwerk AG VIDA 1-Year Sharpe Ratio?

Arzneiwerk AG VIDA FRA:TLIK +0.98% 40 1-Year Sharpe Ratio is 1.01 as of Aug. 31, 2026. GuruFocus rates FRA:TLIK with a GF Score™ of 40/100. The stock has 7 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-08-31), Arzneiwerk AG VIDA's 1-Year Sharpe Ratio is 1.01.

Arzneiwerk AG VIDA  (FRA:TLIK) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Arzneiwerk AG VIDA 1-Year Sharpe Ratio Related Terms

FRA:TLIK vs MCK, COR, CAH: 1-Year Sharpe Ratio Comparison

For the Medical Distribution subindustry, Arzneiwerk AG VIDA's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arzneiwerk AG VIDA 1-Year Sharpe Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Arzneiwerk AG VIDA's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Arzneiwerk AG VIDA's 1-Year Sharpe Ratio falls into.


FRA:TLIK
40GF Score
Arzneiwerk AG VIDA FRA:TLIK
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arzneiwerk AG VIDA 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 1.01 mean?
Arzneiwerk AG VIDA (FRA:TLIK) has a 1-Year Sharpe Ratio of 1.01 as of Aug. 31, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Arzneiwerk AG VIDA and its competitors.
Is Arzneiwerk AG VIDA's 1-Year Sharpe Ratio too high?
Arzneiwerk AG VIDA's current 1-Year Sharpe Ratio is 1.01. Overall, Arzneiwerk AG VIDA has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Arzneiwerk AG VIDA's 1-Year Sharpe Ratio compare to MCK and COR?
Arzneiwerk AG VIDA's 1-Year Sharpe Ratio of 1.01 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Distribution company?
A good 1-Year Sharpe Ratio depends on the Medical Distribution industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Arzneiwerk AG VIDA and its competitors. Arzneiwerk AG VIDA's current 1-Year Sharpe Ratio is 1.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arzneiwerk AG VIDA stock overvalued right now?
Arzneiwerk AG VIDA (FRA:TLIK) has a current 1-Year Sharpe Ratio of 1.01. The current 1-Year Sharpe Ratio is 1.01. Arzneiwerk AG VIDA's overall GF Score™ is 40/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Arzneiwerk AG VIDA (FRA:TLIK), the current 1-Year Sharpe Ratio is 1.01 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arzneiwerk AG VIDA Business Description

Other Exchanges TLIK:Germany
Address Ordensmeisterstrasse 15-16, Berlin, DEU, 12099
Arzneiwerk AG VIDA is active in the pharmaceutical industry. The Pharma segment combines pharmaceutical supply with a focus on digitalization and process optimization along the pharmaceutical value chains and the management of large data volumes in the pharmaceutical industry. The company focuses on the growth area of specialty pharma in Germany and Europe.
40GF Score

Get the complete analysis for FRA:TLIK

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.21
Price